Quantum Cyber N.V.
Quantum Cyber N.V.
Your view on QUCY
Overview
What the company does, where it operates, and who runs it.
About Quantum Cyber N.V.
- Industry
- Medical - Diagnostics & Research
- Sector
- Healthcare
- CEO
- David Elliot Lazar
- Headquarters
- Robert Koch Strasse 50, Mainz, DE
- Industry
- Medical - Diagnostics & Research
- Sector
- Healthcare
- CEO
- David Elliot Lazar
- Headquarters
- Robert Koch Strasse 50, Mainz, DE
Quantum Cyber N.V. operates as a technology company focused on cybersecurity and quantum computing solutions. The company pursues acquisitions and partnerships in areas including post-quantum cryptography, zero-trust architecture, and national security technologies.
It also develops platforms that integrate artificial intelligence (AI) and quantum computing technologies for autonomous control systems used in unmanned aerial, ground, and underwater vehicles, including drones, self-driving vehicles, and robotic fleets. Quantum Cyber N.V. was formerly known as Mainz Biomed N.V. and changed its name to Quantum Cyber N.V. in April 2026.
The company is headquartered in Mainz, Germany.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Quantum Cyber N.V., and the rating behind it. QUCY last traded at $1.45; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Quantum Cyber N.V.. Starting points for Quantum Cyber N.V.: EPS -$1.23, beta 2.38 — an Medical - Diagnostics & Research name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Quantum Cyber N.V.. Quantum Cyber N.V. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Quantum Cyber N.V.. Trailing twelve-month EPS for Quantum Cyber N.V. stands at -$1.23. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Quantum Cyber N.V.. Quantum Cyber N.V. has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Quantum Cyber N.V. valued side by side against its closest peers. Quantum Cyber N.V. is measured against Medical - Diagnostics & Research peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Quantum Cyber N.V., and how their positions are changing. At a $33.0M market value, institutional positions materially move Quantum Cyber N.V.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Quantum Cyber N.V. executives and directors. Shares of Quantum Cyber N.V. have traded between $0.30 and $4.88 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Quantum Cyber N.V.. Quantum Cyber N.V. is a $33.0M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Quantum Cyber N.V.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Quantum Cyber N.V.. Coverage tracks Quantum Cyber N.V. within Medical - Diagnostics & Research (Healthcare). Press releases and market coverage, newest first.
Comments
Comments and replies from FRC members about this company.